Park Ha Biological Technology (BYAH) Cash & Current Investments (2023 - 2026)

Park Ha Biological Technology (BYAH) has reported Cash & Current Investments for 4 consecutive years, with $5.7 million the latest figure, recorded in Q2 2026.

• Quarterly Cash & Current Investments rose 318.68% year-over-year to $5.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $5.7 million (up 318.68% YoY) and the FY2025 annual result came in at $3.8 million, up 591.82% from the prior year.
• Cash & Current Investments grew to $5.7 million in Q2 2026 per BYAH's latest filing, from $3.8 million in the prior quarter.
• Over the last five years, Cash & Current Investments for BYAH reached as high as $5.7 million in Q2 2026 and fell as low as $547498.0 in Q4 2024.
• A 4-year average of $2.5 million and a median of $1.4 million in 2025 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2024 — Cash & Current Investments tumbled 47.03% — and 2025, when it soared 591.82%.
• Year by year, Cash & Current Investments stood at $1.0 million in 2023, then slumped by 47.03% to $547498.0 in 2024, then surged by 591.82% to $3.8 million in 2025, then soared by 49.37% to $5.7 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $5.7 million, $3.8 million, and $1.4 million for Q2 2026, Q4 2025, and Q2 2025 respectively.